Changing interpretations, stable genes: responsibilities of patients, professionals, and policy makers in the clinical interpretation of complex genetic information. Genet Med 2008; 10:778.353 353. David KL, Best RG, Brenman LM, et al. Patient re‐contact after revision of genomic test results: points to consider – a statement of the American College of Medical Genetics and Genomic (ACMG). Genet Med 2019; 21:769.
354 354. Nance MA. Genetic counseling and testing for Huntington's disease: a historical review. Am J Med Genet B Neuropsychiatr Genet 2017; 174:75.
355 355. Borle K, Morris E, Inglis A, et al. Risk communication in genetic counseling: Exploring uptake and perception of recurrence numbers, and their impact on patient outcomes. Clin Genet 2018; 94:239.
356 356. Stuttgen K, Dvoskin R, Bollinger J, et al. Risk perception before and after presymptomatic genetic testing for Huntington's disease: not always what one might expect. Mol Genet Genomic Med 2018; 6:1140.
357 357. Ibisler A, Ocklenburg S, Stemmler S, et al. Prospective evaluation of predictive DNA testing for Huntington's disease in a large German center. J Genet Couns 2017; 26:1029.
358 358. Smit AK, Newson AJ, Best M, et al. Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma. Eur J Hum Genet 2018; 26:1094.
359 359. McGarry A, McDermott MP, Kieburtz K, et al. Risk factors for suicidality in Huntington disease. Neurology 2019; 92:e1643.
360 360. Anderson KE, Eberly S, Marder KS, et al. The choice not to undergo genetic testing for Huntington disease: results from the PHAROS study. Clin Genet 2019; 96:28.
361 361. Tassicker RJ, Teltscher B, Trembath MK, et al. Problems assessing uptake of Huntington's disease predictive testing and a proposed solution. Eur J Hum Genet 2009; 17(1):66.
362 362. Morrision PJ, Harding‐Lester S, Bradley A. Uptake of Huntington disease predictive testing in a complete population. Clin Genet 2011; 80(3):281.
363 363. Baig SS, Strong M, Quarrell OWJ. The global prevalence of Huntingtons disease: a systematic review and discussion. Neurodegener Dis Manag 2016; 6(4):331.
364 364. Baig SS, Strong M, Rosser E, et al. 22 Years of predictive testing for Huntington's disease: the experience of the UK Huntington's Prediction Consortium. Eur J Hum Genet 2017; 25(11):1290.
365 365. Mendes Á, Paneque M, Clarke A, et al. Choosing not to know: accounts of non‐engagement with pre‐symptomatic testing for Machado‐Joseph disease. Eur J Hum Genet 2019; 27:353.
366 366. Cowley L. What can we learn from patients' ethical thinking about the right ‘not to know’ in genomics? Lessons from cancer genetic testing for genetic counselling. Bioethics 2016; 30:628.
367 367. Stark Z, Wallace J, Gillam L, et al. Predictive genetic testing for neurodegenerative conditions: how should conflicting interests within families be managed? J Med Ethics 2016; 42:640.
368 368. Milunsky JM, Maher TA, Loose BA, et al. XL PCR for the detection of large trinucleotide expansions in juvenile Huntington's disease. Clin Genet 2003; 64:70.
369 369. MacLeod RTA, Frontali M, Evers‐Kiebooms G, et al. Recommendations for the predictive genetic test in Huntington's disease. Clin Genet 2013; 23:221.
370 370. Tassicker R, Savulescu J, Skene L, et al. Prenatal diagnosis requests for Huntington's disease when the father is at risk and does not want to know his genetic status: clinical, legal and ethical viewpoints. BMJ 2003; 326:331.
371 371. Van Rij MC, De Rademaeker M, Moutou C, et al. Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centres. Eur J Hum Genet 2012; 20:368.
372 372. Bouchghoul H, Clément SF, Vauthier D, et al. Prenatal testing in Huntington disease: after the test, choices recommence. Eur J Hum Genet 2016; 24:1535.
373 373. Duncan RE, Foddy B, Delatycki MB. Refusing to provide a prenatal test: can it ever be ethical? BMJ 2006; 333:1066.
374 374. Wadrup F, Holden S, MacLeod R, et al. A case‐note review of continued pregnancies found to be at a high risk of Huntington's disease: considerations for clinical practice. Eur J Hum Genet 2019; 27:1215.
375 375. Jones EF, Forrest JD, Henshaw SK, et al. Unintended pregnancy, contraceptive practice and family planning services in developed countries. Fam Plann Perspect 1988; 20:53.
376 376. Tarasoff v. Regents of the University of California, 551 P.2d 334 (Cal. 1976).
377 377. Stol YH, Menko FH, Westerman MJ, et al. Informing family members about a hereditary predisposition to cancer: attitudes and practices among clinical geneticists. J Med Ethics 2010; 36:391.
378 378. Menko FH, Aalfs CM, Henneman L, et al. Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists. Fam Cancer 2013; 12:319.
379 379. Lacroix M, Nycum G, Godard B, et al. Should physicians warn patients' relatives of genetic risk? Can Med Assoc J 2008; 178:593.
380 380. Tan HL, Hofman N, van Langen IM, et al. Sudden unexplained death. Heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005; 112:207.
381 381. Offit K, Groeger E, Turner S, et al. The “duty to warn” a patient's family members about hereditary disease risks. JAMA 2004; 292:1469.
382 382. Marta MR. Genetic testing: do healthcare professionals have a duty to tell a patient's family members that they may be at risk. J Healthc Risk Manag 1999; 19:26.
383 383. Elger BS, Michaud K, Fellmann F, et al. Sudden death: ethical and legal problems of post‐mortem forensic genetic testing for hereditary cardiac diseases. Clin Genet 2010; 77:287.
384 384. Pate v. Threlkel, 661 So. 2d 278, 282 (Fla. 1995).
385 385. Safer v. Estate of Pack, 677 A.2d 1188, 1192‐1193. (N.J. Super. Ct. App. Div.), cert. denied, 683 A.2d 1163 (N.J. 1996).
386 386. Rothstein MA. Reconsidering the duty to warn genetically at‐risk relatives. Genet Med 2018; 20:285.
387 387. N.J. State. Ann § 10:5‐47 (2001).
388 388. Wolf SM, Crock BN, Van Ness B, et al. Managing incidental findings and research reslts in genomic research involving biobanks and archived data sets. Genet Med 2012; 14:361.
389 389. Molloy v. Meier, 679 N.W.2d 711 (Minn. 2004).
390 390. ABC V. St. George's Healthcare NHS Trust [2015] EWHC 1394
391 391. ABC V. St. George's Healthcare NHS Trust [2015] EWCA 336. (QB).
392 392. Lucassen A, Gilbar R. Disclosure of genetic information to relatives: Balancing confidentiality and relatives' interests. J Med Genet 2018; 55:285.
393 393. Royal College of Physicians, Royal College of Pathologists and British Society for Human Genetics. Contest and confidentiality in clinical genetic practice: guidance on genetic testing and sharing genetic information. Report of the Joint Committee on Medical Genetics, 2nd edn. London: Royal College of Physicians/Royal College of Pathologists, 2011.
394 394. General Medical Council. Confidentiality: good practice in handling patient information. London: General Medical Council, 2017, revised in May 2018.
395 395.
